To assess the activity of c-Src in ILC relative to in situ lesions and nonneoplastic epithelium, immunochemistry with the clone 28 antibody was performed on FFPE sections from 57 LBC patients. This evidence concerns the gene SRC and CDH1-related diffuse gastric and lobular breast cancer syndrome.